A comparison of the binding sites of matrix metalloproteinases and tumor necrosis factor-alpha converting enzyme: implications for selectivity
- PMID: 15801829
- PMCID: PMC2896057
- DOI: 10.1021/jm0491703
A comparison of the binding sites of matrix metalloproteinases and tumor necrosis factor-alpha converting enzyme: implications for selectivity
Abstract
MMPs and TACE (ADAM-17) assume independent, parallel, or opposite pathological roles in cancer, arthritis, and several other diseases. For therapeutic purposes, selective inhibition of individual MMPs and TACE is required in most cases due to distinct roles in diseases and the need to preserve activities in normal states. Toward this goal, we compared force-field interaction energies of five ubiquitous inhibitor atoms with flexible binding sites of 24 known human MMPs and TACE. The results indicate that MMPs 1-3, 10, 11, 13, 16, and 17 have at least one subsite very similar to TACE. S3 subsite is the best target for development of specific TACE inhibitors. Specific binding to TACE compared to most MMPs is promoted by placing a negatively charged ligand part at the bottom of S2 subsite, at the entrance of S1' subsite, or the part of S3' subsite that is close to catalytic zinc. Numerous other clues, consistent with available experimental data, are provided for design of selective inhibitors.
Figures






Similar articles
-
Pronounced diversity in electronic and chemical properties between the catalytic zinc sites of tumor necrosis factor-alpha-converting enzyme and matrix metalloproteinases despite their high structural similarity.J Biol Chem. 2004 Jul 23;279(30):31646-54. doi: 10.1074/jbc.M401310200. Epub 2004 Apr 21. J Biol Chem. 2004. PMID: 15102849
-
Matrix metalloproteinase target family landscape: a chemometrical approach to ligand selectivity based on protein binding site analysis.J Med Chem. 2006 Jan 12;49(1):51-69. doi: 10.1021/jm050363f. J Med Chem. 2006. PMID: 16392792
-
Identification of a selectivity determinant for inhibition of tumor necrosis factor-alpha converting enzyme by comparative modeling.Chem Biol. 2003 Mar;10(3):215-23. doi: 10.1016/s1074-5521(03)00044-9. Chem Biol. 2003. PMID: 12670535
-
The application of x-ray, NMR, and molecular modeling in the design of MMP inhibitors.Curr Top Med Chem. 2004;4(12):1311-27. doi: 10.2174/1568026043387999. Curr Top Med Chem. 2004. PMID: 15320728 Review.
-
Design strategies for the identification of MMP-13 and Tace inhibitors.Curr Opin Drug Discov Devel. 2003 Sep;6(5):742-59. Curr Opin Drug Discov Devel. 2003. PMID: 14579524 Review.
Cited by
-
Anthranilate derivatives as TACE inhibitors: docking based CoMFA and CoMSIA analyses.J Mol Model. 2011 Jan;17(1):9-19. doi: 10.1007/s00894-010-0695-7. Epub 2010 Mar 28. J Mol Model. 2011. PMID: 20349256
-
Synthesis, Structure, and SAR of Tetrahydropyran-Based LpxC Inhibitors.ACS Med Chem Lett. 2014 Sep 23;5(11):1213-8. doi: 10.1021/ml500210x. eCollection 2014 Nov 13. ACS Med Chem Lett. 2014. PMID: 25408833 Free PMC article.
-
QM/MM linear response method distinguishes ligand affinities for closely related metalloproteins.Proteins. 2007 Nov 1;69(2):326-39. doi: 10.1002/prot.21500. Proteins. 2007. PMID: 17607744 Free PMC article.
-
Matrix metalloproteinase 2 inhibition: combined quantum mechanics and molecular mechanics studies of the inhibition mechanism of (4-phenoxyphenylsulfonyl)methylthiirane and its oxirane analogue.Biochemistry. 2009 Oct 20;48(41):9839-47. doi: 10.1021/bi901118r. Biochemistry. 2009. PMID: 19754151 Free PMC article.
References
-
- Sternlicht MD, Coussens LM, Vu TH, Werb Z. Biology and regulation of the matrix metalloproteinases. In: Clendeninn NJ, Appelt K, editors. Matrix Metalloproteinase Inhibitors in Cancer Therapy. Humana Press; Totowa, NJ: 2000. pp. 1–37.
-
- Chakraborti S, Mandal M, Das S, Mandal A, Chakraborti T. Regulation of matrix metalloproteinases: An overview. Mol. Cell. Biochem. 2003;253:269–285. - PubMed
-
- Stahl M, Taroni C, Schneider G, Hoffmann F. Mapping of protein surface cavities and prediction of enzyme class by a self-organizing neural network. Protein Eng. 2000;13:83–88. - PubMed
-
- Blobel CP. Functional and biochemical characterization of ADAMs and their predicted role in protein ectodomain shedding. Inflamm. Res. 2002;51:83–84. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous